IMB-0523

N/A

Report date: 2023/04/20 09:43:32
NME

Base Information

Drug NameIMB-0523
Drug Alias NameIMB-0523
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman enterovirus 71 Replication inhibitors
TargetsHuman enterovirus 71
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A